Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Latest News about Payton Nyquvest

Recent news which mentions Payton Nyquvest

Psychedelics-Focused Numinus Plans To Leverage This AI Technology Via New Strategic Acquisition
Tickers NEWS NUMI NUMIF
Tags M&A Cannabis NUMIF
From Benzinga
Payton Nyquvest On Off-Label Markets
Tickers MDMA
Tags Psychedelics contributors News
From Benzinga
'Sea Change': Irwin Naturals, Numinus And Field Trip Discuss Psychedelics At Cantor Webinar
Tickers FTHWF IWINF MNMD NUMIF
Tags REUN Cantor Fitzgerlad Klee Irwin
From Benzinga
Numinus Wellness Inc.'s Q4 And Fiscal 2022 Report Shows Revenues Grew 464% To $4.2M
Tickers NUMIF
Tags Markets Numinus Wellness Inc/ Market News
From Benzinga
Toronto Residents Get New Ketamine-Assisted Therapy Option Close To Home
Tickers NUMIF
Tags Psychedelics Markets Penny Stocks
From Benzinga
Numinus Wellness Announces Q3 Results
Tickers NUMIF
Tags Markets News Psychedelics
From Benzinga
Numinus Submits New Patent Application To UN Agency For Psilocybe & Novel Fungi Species
Tickers NUMIF
Tags Payton Nyquvest United Nations Legal
From Benzinga
New Acquisition: Novamind To Buy Common Shares Of Numinus Pending Canadian Supreme Court Approval
Tickers NUMIF NVMDF
Tags Markets the Supreme Court of British Columbia M&A
From Benzinga
Numinus to Acquire Novamind For $20.74M In Stock
Tickers NUMIF NVMDF
Tags Benzinga Payton Nyquvest NVMDF
From Benzinga
Numinus Wellness Reveals 244.5% YoY Improvement In Q1 Revenue & Wider Loss
Tickers NUMIF
Tags Benzinga Payton Nyquvest Earnings
From Benzinga
Psychedelics Company Numinus Wellness Q4 Revenue Grows 81% YoY Thanks To Mindscape Acquisition
Tickers NUMIF
Tags News Mindspace Psychedelics earnings
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.